Company intelligence
Deep Intelligent Pharma
Transforming pharmaceutical R&D through revolutionary AI-native multi-agent platform technology.
Biotechnology Research
Singapore, SG
15 employees
Founded 2017
2 public signals
About Deep Intelligent Pharma
“Deep Intelligent Pharma (DIP) uses Generative AI to revolutionize clinical trials. Our platform enables pharma and biotech companies to digitally rehearse trials before they begin—making them faster, safer, and more cost-effective. From trial design and patient recruitment to analysis and regulatory reporting, DIP transforms the entire process into an AI-driven, proactive workflow.”
Verified activity
Signals from Deep Intelligent Pharma
2 published signals
Presence & Recognition
Deep Intelligent Pharma is attending DPHARM Boston 2026 to explore AI-driven clinical development and global execution.
Reported by Gang (Gavin) Liu
Presence & Recognition
Deep Intelligent Pharma is a Platinum Sponsor and dedicated forum organiser at the Hong Kong Convention and Exhibition Centre at BIOHK2026.
Reported by Deep Intelligent Pharma